Thrombosis vs Hemostasis, DOACs vs. Factor XIa Inhibitors-Thrombosis vs Hemostasis, DOACs vs. Factor XIa Inhibitors

Thrombosis vs Hemostasis, DOACs vs. Factor XIa Inhibitors

Video Transcription

Video Summary

This video explains how the body balances hemostasis and thrombosis, and how anticoagulants help when clotting becomes harmful. Traditional drugs like warfarin and heparins work but need monitoring and can be unpredictable. Direct oral anticoagulants are more targeted, yet bleeding risk remains a concern. New Factor XI inhibitors may offer a major advance by blocking the clot-amplifying pathway linked more to thrombosis than normal bleeding control. Early trials show low bleeding rates and potential benefits for patients with kidney disease.

Meta Tag

Concept Hemostasis

Concept Thrombosis

Concept Coagulation

Concept Tissue Factor Pathway

Concept Thrombin

Concept Anticoagulant

Keywords

hemostasis

thrombosis

anticoagulants

Factor XI inhibitors

bleeding risk

Hemostasis

Thrombosis

Coagulation

Tissue Factor Pathway

Thrombin

Anticoagulant